This article was originally published in The Tan Sheet
Introducing reformulated Boil-Ease, which contains 20% benzocaine and is indicated for use twice daily over three days. The new product replaces a 5% benzocaine formulation and is expected to comply with FDA's OTC external analgesics monograph. Del proposed dosing at three-to-four-times daily over seven days, but FDA rejected that dosing schedule at an April "OTC feedback" meeting ("The Tan Sheet" April 25, p. 4)
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC